Expertise in
19
conditions

Dr. Bart P. Leroy

Ophthalmology
Office
3401 Civic Center Blvd, 
Philadelphia, PA 
Expertise in
19
conditions
Office
3401 Civic Center Blvd, 
Philadelphia, PA 

Overview

Bart Leroy is an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania.

Dr. Leroy is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Leber Congenital Amaurosis, Retinopathy Pigmentary Mental Retardation, Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

He is actively involved in clinical research, co-authoring 177 peer reviewed articles and participating in 5 clinical trials.

Specialties

Ophthalmology

Licenses

Ophthalmology in PA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
3401 Civic Center Blvd, Philadelphia, PA 19104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Enrollment Status: Completed
Publish Date: April 16, 2026
Intervention Type: Genetic, Drug
Study Phase: Phase 3
Translational Stem Cell Research in Ophthalmology - Regenerating the Anterior Cornea Through Standardized Transplantation of Limbal Epithelial Stem Cells: a Phase II Multicenter Trial
Translational Stem Cell Research in Ophthalmology - Regenerating the Anterior Cornea Through Standardized Transplantation of Limbal Epithelial Stem Cells: a Phase II Multicenter Trial
Enrollment Status: Completed
Publish Date: January 15, 2025
Intervention Type: Biological
Study Drug: Limbal epithelial stem cell graft
Study Phase: Phase 2
An Open-Label, Extension Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
An Open-Label, Extension Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Enrollment Status: Terminated
Publish Date: October 15, 2024
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Evaluation of Light Sensitivity and Visual Acuity Changes as Consequence of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris
Evaluation of Light Sensitivity and Visual Acuity Changes as Consequence of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris
Enrollment Status: Terminated
Publish Date: April 27, 2022
Intervention Type: Device, Drug
Study Phase: Not Applicable
Double-masked, Randomized, Controlled, Multiple-dose Study to Evaluate Efficacy, Safety, Tolerability and Syst. Exposure of QR-110 in Leber's Congenital Amaurosis (LCA) Due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Double-masked, Randomized, Controlled, Multiple-dose Study to Evaluate Efficacy, Safety, Tolerability and Syst. Exposure of QR-110 in Leber's Congenital Amaurosis (LCA) Due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Enrollment Status: Active_not_recruiting
Publish Date: March 17, 2022
Intervention Type: Other, Drug
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials

177 Total Publications

Telemanipulated Robot-Assisted Vitreoretinal Surgery: Safety and Effectiveness of the Luca™ System in robotically performed core vitrectomy in ERM or Macular Hole Surgical Treatment Safety and feasibility of Luca™ System.
Telemanipulated Robot-Assisted Vitreoretinal Surgery: Safety and Effectiveness of the Luca™ System in robotically performed core vitrectomy in ERM or Macular Hole Surgical Treatment Safety and feasibility of Luca™ System.
Journal: Retina (Philadelphia, Pa.)
Published: August 07, 2026
Similar Doctors
Expertise in
49
conditions
Dr. Carol L. Shields
Ophthalmology | Oncology
Expertise in
49
conditions
Dr. Carol L. Shields
Ophthalmology | Oncology
Referral may be required
Before you request

Ophthalmology - Wills Eye Hospital

840 Walnut Street, Floor 10, 
Philadelphia, PA 
 (2.1 miles away)
215-928-3105
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Carol Shields is an Oncologist and an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania. Dr. Shields is highly rated in 49 conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Uveal Melanoma, Vitrectomy, and Iridectomy. Dr. Shields is board certified in Ophthalmology. Dr. Shields is currently accepting new patients.

Expertise in
28
conditions
Dr. Tomas S. Aleman
Ophthalmology
Expertise in
28
conditions
Dr. Tomas S. Aleman
Ophthalmology
Referral may be required
Before you request

Scheie Eye Institute Perelman

3400 Civic Center Boulevard, West Pavilion, 3rd Floor, 
Philadelphia, PA 
 (0.1 miles away)
215-662-8100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Tomas Aleman is an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania. Dr. Aleman is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Choroideremia, Leber Congenital Amaurosis, Retinopathy Pigmentary Mental Retardation, Cone-Rod Dystrophy, and Vitrectomy. Dr. Aleman is board certified in Ophthalmology, 2019. Dr. Aleman is currently accepting new patients.

Expertise in
27
conditions
Dr. Allen C. Ho
Ophthalmology
Expertise in
27
conditions
Dr. Allen C. Ho
Ophthalmology
Referral may be required
840 Walnut Street, Floor 10, 
Philadelphia, PA 
 (2.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Allen Ho is an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania. Dr. Ho is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, Vitrectomy, and Cataract Removal. Dr. Ho is board certified in Ophthalmology. Dr. Ho is currently accepting new patients.

Frequently Asked Questions about Dr. Bart P. Leroy

How do I make an appointment with Dr. Bart P. Leroy?

You can book an appointment with Dr. Bart P. Leroy by calling their office at 215-590-2791. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Bart P. Leroy a top-rated expert for Leber Congenital Amaurosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Bart P. Leroy is classified as an Elite expert for Leber Congenital Amaurosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Bart P. Leroy specialize in?

While Dr. Bart P. Leroy is a Ophthalmology, they have specific expertise in Leber Congenital Amaurosis, Retinopathy Pigmentary Mental Retardation, and Late-Onset Retinal Degeneration. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.

Does Dr. Bart P. Leroy participate in research or clinical trials?

Yes. Dr. Bart P. Leroy has published 177 articles and abstracts on conditions like Leber Congenital Amaurosis. You can view a list of Dr. Bart P. Leroy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Leroy's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 21 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile